Three things to know:
1. Link Spine had been searching for an acquiring company that could advance its spinal fusion system, which is focused on facet fixation and minimally invasive surgery.
2. Celling Spine believes Link Spine’s technology supports its current product line and will assist in the development of a biologically enhanced spinal fusion system.
3. The company is using spine implant systems and developing biological improvements to maximize the body’s natural healing cascade.
“We have always maintained that the future of medicine will rely on cells and the environment in tissue restoration and regeneration that cells play a part,” said Kevin Dunworth, founder of Celling Spine. “With the addition of the Link product portfolio we are able to rely on an innovative spinal fusion system that gives the cells everything it needs to optimize the fusion.”
More articles on devices:
Saluda Medical raises $75M for spinal cord stimulation
Fusion Robotics to advance spinal robotic devices
Alexion drug receives FDA approval for rare autoimmune disease of spinal cord
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.